SF5187

Use of step therapy protocols prohibition for the treatment of neurological conditions
Legislative Session 94 (2025-2026)

Related bill: HF4357

Bill text

Introduction

ReadChanges
PDF
(underlined = new law, struck through = current law the bill removes)
1.1A bill for an act
1.2relating to health insurance; prohibiting the use of step therapy protocols for the
1.3treatment of neurological conditions; proposing coding for new law in Minnesota
1.4Statutes, chapter 62Q.
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.6Section 1. new text begin [62Q.1842] PROHIBITION ON USE OF STEP THERAPY PROTOCOLS new text end
1.7 new text begin FOR NEUROLOGICAL CONDITIONS. new text end
1.8 new text begin Subdivision 1. Definitions. (a) For purposes of this section, the following terms have new text end
1.9 new text begin the meanings given. new text end
1.10 new text begin (b) "Clinical practice guideline" has the meaning given in section 62Q.184, subdivision new text end
1.11 new text begin 1, paragraph (b). new text end
1.12 new text begin (c) "Neurological condition" means a disorder, whether resulting from accident or illness, new text end
1.13 new text begin that causes an impairment in neurological function. new text end
1.14 new text begin (d) "Step therapy protocol" has the meaning given in section 62Q.184, subdivision 1, new text end
1.15 new text begin paragraph (e). new text end
1.16 new text begin Subd. 2. Prohibition on use of step therapy protocols. A health plan that covers new text end
1.17 new text begin treatment for neurological conditions must not limit or exclude coverage for a drug that is new text end
1.18 new text begin approved by the United States Food and Drug Administration and included on the health new text end
1.19 new text begin plan's prescription drug formulary by requiring an enrollee with a neurological condition new text end
1.20 new text begin to follow a step therapy protocol if the approved drug's use is consistent with: new text end
1.21 new text begin (1) a United States Food and Drug Administration-approved indication; and new text end
1.22 new text begin (2) a clinical practice guideline. new text end
2.1 new text begin EFFECTIVE DATE. This section is effective January 1, 2027, and applies to health new text end
2.2 new text begin plans offered, issued, or renewed on or after that date. new text end

Bill information comes from public records published by the Office of the Revisor of Statutes, the Minnesota House and the Minnesota Senate. AI summaries are written by MinneSlate and are not official. MinneSlate is independent and is not affiliated with the State of Minnesota or the Minnesota Legislature.

Progress through the legislative process

17%
In Committee
Loading…